Nuvation Bio (NUVB) Profit After Tax (2023 - 2025)
Historic Profit After Tax for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$55.8 million.
- Nuvation Bio's Profit After Tax fell 3538.46% to -$55.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$217.5 million, marking a year-over-year increase of 5914.19%. This contributed to the annual value of -$567.9 million for FY2024, which is 64924.01% down from last year.
- According to the latest figures from Q3 2025, Nuvation Bio's Profit After Tax is -$55.8 million, which was down 3538.46% from -$59.0 million recorded in Q2 2025.
- Nuvation Bio's 5-year Profit After Tax high stood at -$13.8 million for Q4 2023, and its period low was -$462.5 million during Q2 2024.
- Over the past 3 years, Nuvation Bio's median Profit After Tax value was -$41.2 million (recorded in 2024), while the average stood at -$73.8 million.
- As far as peak fluctuations go, Nuvation Bio's Profit After Tax crashed by 214075.58% in 2024, and later soared by 8724.15% in 2025.
- Nuvation Bio's Profit After Tax (Quarter) stood at -$13.8 million in 2023, then tumbled by 258.63% to -$49.4 million in 2024, then decreased by 12.84% to -$55.8 million in 2025.
- Its last three reported values are -$55.8 million in Q3 2025, -$59.0 million for Q2 2025, and -$53.2 million during Q1 2025.